These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7333195)

  • 1. [Long-term observation of HBsAg positive patients and carriers (author's transl)].
    Wu BP
    Zhonghua Yu Fang Yi Xue Za Zhi; 1981 Jul; 15(4):245-7. PubMed ID: 7333195
    [No Abstract]   [Full Text] [Related]  

  • 2. [Long term follow-up of non-symptomatic HBsAg carriers].
    González A; Vargas V; Hernández-Sánchez JM; Cortina M; Pelegrí D; López-Talavera JC; Genescá J; Jardí R; Esteban R; Guardia J
    An Med Interna; 1991 Jun; 8(6):269-72. PubMed ID: 1888839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A follow-up study on HBsAg carriers and factors affecting negative-conversion].
    Hong DQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 1984 Jan; 18(1):32-4. PubMed ID: 6468123
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunogenetic studies on etiology of liver disease --HLA in asymptomatic carriers with positive HBs-Ag (author's transl)].
    Morita N; Shingami T; Shiwaku Y; Mori H; Nakao Y; Hashimoto S
    Igaku Kenkyu; 1979 Sep; 49(3):249-50. PubMed ID: 547641
    [No Abstract]   [Full Text] [Related]  

  • 5. [Changes in laboratory test values after physical exercise in symptom-free HBsAg carriers (author's transl)].
    Veselý V; Pribil M; Pribilová A; Kulich V
    Cas Lek Cesk; 1980 Sep; 119(36-37):975-7. PubMed ID: 7438171
    [No Abstract]   [Full Text] [Related]  

  • 6. [106 cases of HBsAg carriers and factors influencing the prognosis: a follow-up study of 7-12 years].
    Hong DQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 1985 Aug; 6(4):223-6. PubMed ID: 4092225
    [No Abstract]   [Full Text] [Related]  

  • 7. [A follow-up study on 103 HBsAg carriers during 16-21 years].
    Hong DQ; Li JS; Dai HM
    Zhonghua Yu Fang Yi Xue Za Zhi; 1994 Sep; 28(5):287-90. PubMed ID: 7842894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Observation on dynamics of 131 cases of HBsAg carriers].
    Zhonghua Liu Xing Bing Xue Za Zhi; 1983 Dec; 4(6):326-8. PubMed ID: 6675853
    [No Abstract]   [Full Text] [Related]  

  • 9. [The quantitative determination of HBSAG--a valuable aid in evaluating the infectiousness of hepatitis B virus carriers].
    Löschner J; Fengler JD; Baumgarten R
    Z Arztl Fortbild (Jena); 1981 Nov; 75(22):1084-5. PubMed ID: 7340196
    [No Abstract]   [Full Text] [Related]  

  • 10. [Dynamics examination of eliminating surface antigen of Hepatitis B Virus (HBsAg) and its significance for the prognosis of the disease and the carrier state (author's transl)].
    Pejcochová J; Jandásek L; Jezek P; Horecká J
    Cesk Epidemiol Mikrobiol Imunol; 1978 Apr; 27(2):79-83. PubMed ID: 149606
    [No Abstract]   [Full Text] [Related]  

  • 11. [HLA antigens in blood donors, asymptomatic chronic carriers of the viral hepatitis type B surface antigen (HBsAg)].
    Morales VH; Barbetti A; Basualdo JA; Jmelnitzky A; Landoni N; Ponce de León H; Chopita N; de Torres RA
    Medicina (B Aires); 1983; 43(2):175-80. PubMed ID: 6664285
    [No Abstract]   [Full Text] [Related]  

  • 12. Serological profiles of hepatitis B carrier patients in Singapore with special reference to the frequency and significance of concurrent presence of HBsAg and anti-HBs.
    Wang YM; Ng WC; Kang JY; Yap I; Seet BL; Teo J; Smith R; Guan R
    Singapore Med J; 1996 Apr; 37(2):150-2. PubMed ID: 8942251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between ADCC effector cells and the combination therapy of pantethine and lecithin--a proposal for management of patients with HBsAg carrier state (author's transl)].
    Murata T; Oniki H; Kimura Y; Komoda T; Yamashita Y; Nakamura S; Koga Y
    Igaku Kenkyu; 1981 Oct; 51(4):213-23. PubMed ID: 7331739
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cellular immunity in hepatitis type B--mixed lymphocyte culture of peripheral blood from HBs-Ag carriers (author's transl)].
    Nozaki H; Tsuji T; Nagashima H
    Rinsho Byori; 1978 Feb; 26(2):153-8. PubMed ID: 147352
    [No Abstract]   [Full Text] [Related]  

  • 15. [Positive HBsAg in 3 sisters carrying identical HLA].
    Marzo L; Buñuel C; Aztarain E; Raichs A
    Sangre (Barc); 1984; 29(1):93-4. PubMed ID: 6719323
    [No Abstract]   [Full Text] [Related]  

  • 16. [Significance of prospective follow-up cohort study in diagnosis and treatment of primary hepatic cancer among HBsAg carriers].
    Lu P; Wang J; Wu Y
    Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(14):856-9. PubMed ID: 11702680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunologic aspects of asymptomatic chronic carriers of HBsAg].
    Fink de Cabutti NE; Morales VH; Jmlenitzky C; Basualdo Farjat JA; De Torres R
    Sangre (Barc); 1984; 29(4-A):370-5. PubMed ID: 6505927
    [No Abstract]   [Full Text] [Related]  

  • 18. [The incidence of hepatitis B and HBsAg carrier state in families caused by (nonparenteral) contact].
    Horejsí J; Cerhová M; Jezková Z; Májský A; Mimra J; Novák J; Svorcová V
    Vnitr Lek; 1980 Apr; 26(4):234-41. PubMed ID: 7385610
    [No Abstract]   [Full Text] [Related]  

  • 19. [Preliminary studies on HBsAg excretion from saliva in healthy carriers and epidemiological pattern of hepatitis B (author's transl)].
    Cao HL; Wang FL; Du XL; Chen SX; Wang Y; Liu CB
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1981 Sep; 3(3):179-82. PubMed ID: 6459179
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antigen-specific detection and assay of serum HBsAG-AB-immune complexes in HBV carriers (author's transl)].
    Tsuji T; Tsuchiya M; Araki K; Shinohara T; Onoe K
    Nihon Shokakibyo Gakkai Zasshi; 1980 May; 77(5):806. PubMed ID: 6157039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.